NACHI-FUJIKOSHI announced a stock split to divide each share into 5 shares and set 30 November as the record date. It also released its financial results.
The Nikkei 225 rebounded, briefly recovering to the ¥70,000 range on gains in U.S. stocks. The strength of the U.S. equity market lifted Japanese stocks as well, providing a catalyst for a broad market advance.
NACHI-FUJIKOSHI decided to split each share into 5 shares and indicated that 30 November would be the record date for the split. The company also announced its financial results, and investors are watching both the split and the results.
Developments in several other stocks, including Carna Biosciences, SanBio and Renascience, were also reported. The coverage included information on the signing of a clinical trial agreement, patent-related developments and progress in clinical trials for therapeutic drugs. The start of shipments of HEALIOS's conditioned medium products and Asteria's selection for a new demonstration project were also covered.
Individual-stock news, including Sodick's share buyback and secondary offering and changes in Infomart's shareholding ratio, was introduced as part of the market discussion.